SEC Form 4 · accession 0001140361-16-075829
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Sulpizio
Director
Period of report
Aug 10, 2016
Accepted (ET)
Aug 11, 2016 · 2:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Aug 10, 2016 | M | 36,000 | $25.54 | A | 101,887 | D | |
| ResMed Common StockF1 | Aug 10, 2016 | S | 36,000 | $70.147 | D | 65,887 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $25.54 | Aug 10, 2016 | M | 36,000 | D | Nov 11, 2012 | Dec 17, 2016 | ResMed Commmon Stock | 36,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $70.04 to $70.33. The price reported above reflects the weighted average sale price.
- F2Represents date options first became exercisable. Options fully vest the third year after the grant date.